Michael Ryskin
Stock Analyst at Bank of America Securities
(4.36)
# 1,279
Out of 5,076 analysts
715
Total ratings
59.4%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintained: Buy | $265 | $243.28 | +8.93% | 18 | Oct 23, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $650 → $795 | $676.54 | +17.51% | 31 | Oct 22, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $180 → $190 | $173.89 | +9.26% | 27 | Oct 13, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | n/a | $339.66 | - | 20 | Sep 28, 2026 | |
| PAHC Phibro Animal Health | Reiterated: Sell | $35 | $39.81 | -12.08% | 16 | Aug 27, 2026 | |
| IDXX IDEXX Laboratories | Reiterated: Hold | $660 → $665 | $566.76 | +17.33% | 33 | Aug 14, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $32 → $34 | $22.69 | +49.85% | 36 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Hold | $27 → $31 | $29.72 | +4.31% | 2 | Aug 10, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | n/a | $69.75 | - | 28 | Aug 7, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | n/a | $31.71 | - | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.60 | - | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $57.31 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $140 | $269.40 | -48.03% | 48 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.50 | - | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $400 → $415 | $455.59 | -8.91% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $229.75 | +0.11% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.2 | $5.76 | -44.44% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $52 | $63.81 | -18.51% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $162.94 | - | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,684.64 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $155.51 | - | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $23.92 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 → $160 | $185.57 | -13.78% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $360 | $329.93 | +9.11% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $280 | $278.32 | +0.60% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $82.00 | - | 44 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 | $394.03 | +4.05% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.4 | $1.54 | +55.84% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $16 | $16.39 | -2.38% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $157.36 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $49 | $50.22 | -2.43% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $17.15 | -35.86% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $7.07 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $10.09 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 | $9.71 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $2.4 | $9.37 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.58 | n/a | 2 | Apr 18, 2022 |
Quest Diagnostics
Oct 23, 2026
Maintained: Buy
Price Target: $265
Current: $243.28
Upside: +8.93%
Thermo Fisher Scientific
Oct 22, 2026
Reiterated: Buy
Price Target: $650 → $795
Current: $676.54
Upside: +17.51%
Agilent Technologies
Oct 13, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $173.89
Upside: +9.26%
Charles River Laboratories International
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $339.66
Upside: -
Phibro Animal Health
Aug 27, 2026
Reiterated: Sell
Price Target: $35
Current: $39.81
Upside: -12.08%
IDEXX Laboratories
Aug 14, 2026
Reiterated: Hold
Price Target: $660 → $665
Current: $566.76
Upside: +17.33%
Elanco Animal Health
Aug 12, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $22.69
Upside: +49.85%
Alamar Biosciences
Aug 10, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $29.72
Upside: +4.31%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $69.75
Upside: -
Caris Life Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.71
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.60
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $57.31
Upside: -
Aug 5, 2026
Reiterated: Sell
Price Target: $140
Current: $269.40
Upside: -48.03%
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.50
Upside: -
Aug 4, 2026
Reiterated: Hold
Price Target: $400 → $415
Current: $455.59
Upside: -8.91%
Aug 3, 2026
Reiterated: Buy
Price Target: $230
Current: $229.75
Upside: +0.11%
Aug 3, 2026
Reiterated: Sell
Price Target: $4 → $3.2
Current: $5.76
Upside: -44.44%
Aug 3, 2026
Reiterated: Hold
Price Target: $64 → $52
Current: $63.81
Upside: -18.51%
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $162.94
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,684.64
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $155.51
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $23.92
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: $150 → $160
Current: $185.57
Upside: -13.78%
Jul 30, 2026
Reiterated: Buy
Price Target: $320 → $360
Current: $329.93
Upside: +9.11%
Jul 28, 2026
Reiterated: Buy
Price Target: $245 → $280
Current: $278.32
Upside: +0.60%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $82.00
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $410
Current: $394.03
Upside: +4.05%
Jul 15, 2026
Reiterated: Sell
Price Target: $2.4
Current: $1.54
Upside: +55.84%
Jul 13, 2026
Reiterated: Hold
Price Target: $11 → $16
Current: $16.39
Upside: -2.38%
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $157.36
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $56 → $49
Current: $50.22
Upside: -2.43%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $17.15
Upside: -35.86%
Mar 3, 2025
Reiterated: Buy
Price Target: $9 → $8
Current: $7.07
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $10.09
Upside: n/a
Jul 18, 2024
Reiterated: Sell
Price Target: $10
Current: $9.71
Upside: n/a
Apr 24, 2023
Reiterated: Sell
Price Target: $10 → $2.4
Current: $9.37
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.58
Upside: n/a